Adaptive Biotechnologies
PublicAdaptive Biotechnologies is now publicly traded
The data on this page reflects Adaptive Biotechnologies's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 26, 2019
Last Round
Debt
Sep 12, 2022
Total Funding Raised
$1.21B
Company Overview
Adaptive Biotechnologies is a biotechnology company that develops an immune medicine platform for the diagnosis and treatment of various diseases, including cancer and autoimmune conditions.
Sector
Biotech
AI Layer
Application
Keywords
minimal residual diseaseMRDclonoSEQimmune repertoire sequencingcancer diagnosticsimmunomicsT-cell receptorimmune medicinebiomarker discoveryliquid biopsyDNA sequencingdrug discoveryclinical diagnosticsprecision oncologyAI-driven biotech
Adaptive Biotechnologies Comparables
Compare Adaptive Biotechnologies with similar companies based on industry and business-model similarity.
Adaptive Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 12, 2022 | ||||
| Follow-on Offering | Jul 15, 2020 | ||||
| IPO | Jun 26, 2019 | ||||
| Series F Extension | Dec 11, 2017 | ||||
| Series F | May 6, 2015 | ||||
Series E | Jan 7, 2015 |
Key People
Founding team and executive leadership
Adaptive Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guggenheim Securities | IPO, Follow-on Offering |
| BofA Securities | Follow-on Offering |
| OrbiMed | Debt |
| BD Biosciences | Series F |
| Walden Venture Capital | Series A |
| Viking Global Investors | Series F, Series F Extension, Series C |
| Senator Investment Group | Series F |
Adaptive Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSeattle, Washington
Employee Range652
Year Founded2009
Last FundingSep 12, 2022